Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Pallas Health vs RxSpan MD

By GLP-1 ScorecardUpdated

Pallas HealthFactor scores not reassessed.
Site position #142

Lower score

RxSpan MD
Site position #4

Higher score

Score comparison

RxSpan MD has the higher recorded score — 84.3/100 to 69.3/100.

RxSpan MD grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. RxSpan MD's live catalog lists brand-name GLP-1 drugs, while its homepage also advertises compounded plans; confirm the actual product and total price before enrolling.

Before you choose

RxSpan MD does not publish a semaglutide price, so its RxSpan MD review sets out what it does disclose, while the Pallas Health review explains the conditions attached to Pallas Health's figure. The semaglutide cost page compares published rates across the field. Ask RxSpan MD for a written total before treating either one as the cheaper choice.

If neither one fits, Pallas Health vs Synergy Rx and Peptivo vs RxSpan MD compare each of them with another graded program, and the list of alternatives to Pallas Health ranks the programs closest to Pallas Health on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.

We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.

Factor by factor

These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.

Cost valueRxSpan MD +31
55
86
Dose & formulationRxSpan MD +13
76
89
Clinical oversightRxSpan MD +4
84
88
Labs & monitoringRxSpan MD +31
52
83
FulfillmentRxSpan MD +3
86
89
Contract termsPallas Health +15
68
53
Pallas Health · top barRxSpan MD · bottom bar

The numbers

Swipe or scroll to compare both providers.

MetricPallas HealthRxSpan MD
WeighScore69.3/10084.3/100
GradeCB
Site position#142#4
Semaglutide$139 first period, then $199 every four weeks (compounded; confirm selected quote)Current compounded quote unconfirmed
Tirzepatide$179 first period, then $299 every four weeks (compounded; confirm selected quote)Current compounded quote unconfirmed
CoverageConfirm treatment and visit requirements for your stateConfirm treatment availability during intake
Brand-name accessYesYes
Oral / sublingualNot confirmedNot confirmed
Pallas Health

Site position #142 · C

Factor scores not reassessed.

Strengths

  • Publishes first-period and four-week renewal amounts
  • Explains when the charge is triggered and how to cancel future renewal
  • Terms link to a pharmacy partner directory

What to consider

  • Annual monthly equivalents do not establish the selected debit
  • Once prescribed, the current cycle ordinarily is not prorated or refunded
  • The six-month promise has separate eligibility and timing requirements
RxSpan MD

Site position #4 · B

Strengths

  • Current public catalog lists Ozempic, Wegovy, Mounjaro and Zepbound
  • Public terms describe independent healthcare providers
  • Homepage describes messaging and care-team appointments

What to consider

  • Homepage advertises compounded plans that the current catalog did not substantiate
  • Current oral GLP-1 availability is unconfirmed
  • Prior compounded prices are not a current quote; selected dose, supply, pharmacy and fee inclusions need confirmation
  • Public terms do not establish unused prepaid-treatment refund amounts

Featured provider

RxSpan MD

RxSpan MD scores 84.3/100 (B). RxSpan MD's live catalog lists brand-name GLP-1 drugs, while its homepage also advertises compounded plans; confirm the actual product and total price before enrolling.

Commercial relationships affect this placement. The score comparison above is separate.

Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.

← Back to the scorecard